May 30, 2024, 08:23 AM by

PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights. The product pairing provides unprecedented single-cell and spatial resolution of the tumor microenvironment from routine pathology samples to facilitate biomarker discovery and deeper understanding of treatment response for the next generation of cancer therapeutics. The expansion of the Explore™ portfolio comes at a time when AI-pathology is experiencing accelerated large-scale adoption across the diagnostic and biopharma industries.

May 30, 2024, 08:23 AM by

May 30, 2024, 08:20 AM by

Sakura Finetek Europe announces the launch of its newest advancement in tissue sample identification bringing laboratory workflows to the next level.

May 30, 2024, 08:20 AM by

May 30, 2024, 08:20 AM by

Indica Labs announced today the release of the transformative new version of its industry leading life sciences software.

May 30, 2024, 05:00 AM by User Not Found

Bio-IT World | A consortium of pancreatic cancer researchers sharing information in real time has shown that an oral pan-RAS inhibitor known as RMC-7977, developed by Revolution Medicines, effectively targets the common cancer-causing RAS proteins while minimally impacting normal cells—and did so across a comprehensive range of preclinical models in a series of similar experiments.

May 29, 2024, 05:00 AM by User Not Found

Bio-IT World | Ambry Genetics and PacBio to support the Pediatric Mendelian Genomics Research Center (MGRC) program to better understand the underlying biology of rare diseases; Recursion’s BioHive-2 was dubbed No. 35 on the latest TOP500 list of the world’s fastest supercomputers; the Catalogue of Somatic Mutations in Cancer (COSMIC) launches its 100th version; more.

May 28, 2024, 15:07 PM by

May 28, 2024, 15:07 PM by

May 28, 2024, 15:07 PM by

New independent study’s findings presented during Presidential Plenary session at Digestive Disease Week 2024.

May 28, 2024, 15:07 PM by

May 28, 2024, 15:07 PM by

May 28, 2024, 15:07 PM by

May 28, 2024, 05:00 AM by User Not Found

Bio-IT World | Laurence Belfer gifts funds to MD Anderson Cancer Center to strengthen neurodegeneration research through the Belfer Neurodegeneration Consortium; CN Bio plans to accelerate its expanding product portfolio; more.

May 24, 2024, 07:39 AM by

PathAI, a global leader in AI-powered pathology, and Aster Insights, the leading provider of scientific and clinical intelligence for oncology discovery, today announced a multi-year strategic partnership to develop curated multimodal datasets that pair PathAI’s PathExplore1 artificial intelligence (AI) tumor microenvironment (TME) quantification panel with Aster Insights’ Avatar clinical, molecular, and digital pathology imaging data. By combining their respective best-in-class platforms, PathAI and Aster Insights will be able to expedite the development of novel insights to accelerate the discovery and development of new treatments for patients with cancer.

May 24, 2024, 07:39 AM by

Domestic and international markets in Asia surging as CPHI & PMEC China welcomes 60,000 attendees and 3500 exhibitors

May 24, 2024, 07:39 AM by

Today, Owkin has unveiled its precision AI drug pipeline in oncology & immunology. To accelerate time-to-patient impact, Owkin has in-licensed OKN4395, a highly selective and potent EP2/4 dual antagonist from Idorsia that will enter Phase 1 trials in early 2025.

May 24, 2024, 07:39 AM by

May 24, 2024, 07:39 AM by

Qlucore, listed on Nasdaq First North, can now release a new version of Qlucore Insights specifically designed for the lung cancer field, with the capability to classify primary lung samples as well as metastatic lesions. The lung cancer model is being developed with Heidelberg University Hospital, supported by a Eurostars Joint European Programme grant.

May 23, 2024, 08:10 AM by